# Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

> **NCT02462603** · PHASE2 · COMPLETED · sponsor: **Edison Pharmaceuticals Inc** · enrollment: 44 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** PTC-589

## Key facts

- **NCT ID:** NCT02462603
- **Lead sponsor:** Edison Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-17
- **Primary completion:** 2019-01-08
- **Final completion:** 2019-01-08
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02462603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02462603, "Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02462603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*